PEG-liposomal oxaliplatin induces apoptosis in human: Colorectal cancer cells via FAS/FASL and caspase-8

Cell Biology International

Volumn 36, Issue 3, 2012, Pages 289-296

  Yang, Chuang ^a,b   Liu, Hai Zhong ^b   Fu, Zhong Xue ^a  

^a Department of Hepatobiliary Surgery   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; Liposome; Oxaliplatin

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; FAS LIGAND; LIPOSOME; MACROGOL; OXALIPLATIN; PROTEIN BID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; NICK END LABELING; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; COLORECTAL NEOPLASMS; FAS LIGAND PROTEIN; HUMANS; LIPOSOMES; ORGANOPLATINUM COMPOUNDS; POLYETHYLENE GLYCOLS; SIGNAL TRANSDUCTION;

EID: 84859233464     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100825     Document Type: Article

References (40)

1. Abu-Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H. Oxaliplatin encapsulated in PEG-coated cationic liposome induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release 2009a;137:8-14.
2. Abu-Lila A, Suzuki T, Doi Y, Ishida T, Kiwada H. Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposome suppresses the angiogenesis in a dorsal air sac mouse model. J Control Release 2009b;134:18-25.
3. Bullani RR, Wehrli P, Viard-Leveugle I, Rimoldi D, Cerottini JC, Saurat JH et al. Frequent down-regulation of Fas (CD95) expression and function in melanoma. Melanoma Res 2002;12:263-70.
4. Carvalho Júnior AD, Vieira FP, Melo VJ, Lopes MT, Silveira JN, Ramaldes GA et al. Preparation and cytotoxicity of cisplatin-containing liposome. Braz J Med Biol Res 2007;40:1149-57.
5. Chen G, Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science 2002;296:1634-5.
6. Chen L, Zhuang G, Li W, Liu Y, Zhang J, Tian X. RGD-FasL induces apoptosis of pituitary adenoma cells. Cell Mol Immunol 2008;5:61-8.
7. Chen L, Tian X, Li W, Agarwal A, Zhuang G. Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas. Neurol India 2009;57:28-30.
8. Di Renzo M, Serrano D, Zhou Z, George I, Becker K, Cunningham-Rundles C. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS. Clin Exp Immunol 2001;125:117-22.
9. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 1988;85:6949-53.
10. Gabizon AA. Stealth liposome and tumor targeting: a step further in the quest for the magic bullet. Clin Cancer Res 2001;7:223-5.
11. Gonzalvez F, Pariselli F, Jalmar O, Dupaigne P, Sureau F et al. Mechanistic issues of the interaction of the hairpin-forming domain of tBid with mitochondrial cardiolipin. PLoS ONE 2010;5:e9342.
12. Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A. Nuclear delivery of doxorubicin via folate-targeted liposome with bypass of multidrug-resistance efflux pump. Clin Cancer Res 2000;6:1949-57.
13. Hong M, Zhu S, Jiang Y, Tang G, Pei Y. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 2009;133:96-102.
14. Honnma H, Endo T, Henmi H, Nagasawa K, Baba T, Yamazaki K et al. Altered expression of Fas/Fas ligand/caspase8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis 2006;11:1525-33.
15. Hsu SC, Gavrilin MA, Lee HH, Wu CC, Han SH, Lai MZ. NF-kappa Bdependent Fas ligand expression. Eur J Immunol 1999;29:2948-56.
16. Hua F, Cornejo MG, Cardone MH, Stokes, CL, Lauffenburger DA. mEffects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. J Immunol 2005;175:985-95.
17. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Clin Immunol 2006;120:297-309.
18. Hussain S, Pluckthun A, Allen TM, Zangemeister-Wittke U. Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system. Mol Cancer Ther 2007;6:3019-27.
19. Jost PJ, Grabow S, Gray D, McKenzie MD, Nachbur U, Huang, DC et al. XIAP discriminates between type I and type II FAS-induced apoptosis. Nature 2009;460:1035-9.
20. Kim BM, Choi YJ, Han Y, Yun YS, Hong SH. N, N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells. Toxicol Appl Pharmacol 2009a;239:87-97.
21. Kim YS, Lee HJ, Jang C, Kim HS, Cho YJ. Knockdown of RCAN1.4 increases susceptibility to FAS-mediated and DNA-damageinduced apoptosis by upregulation of p53 expression. Korean J Physiol Pharmacol 2009b;13:483-9.
22. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Proapoptotic cascade activates Bid, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000;7:1166-73.
23. Lammers T, Hennink WE, Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008;99:392-7.
24. Lappalainen K, Miettinen R, Kellokoski J, Jääskeläinen I, Syrjänen S. Intracellular distribution of oligonucleotides delivered by cationic liposome: light and electron microscopic study. J Histochem Cytochem 1997;45:265-74.
25. Lee CM, Tanaka T, Murai T, Kondo M, Kimura J, Su W et al. Novel chondroitin sulfate-binding cationic liposome loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res 2002;62:4282-8.
26. Lin ML, Lu YC, Chung JG, Li YC, Wang SG, NG SH et al. Aloe-emodin induces apoptosis of human nasopharyngeal carcinoma cells via caspase-8-mediated activation of the mitochondrial death pathway. Cancer Lett 2010;291:46-58.
27. Marchetti P, Galla DA, Russo FP, Ricevuto E, Flati V, Porzio G et al. Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line. Anticancer Res 2004;24:219-26.
28. Nadal C, Rosa JM, Antoni RG, Castells RL, Sergi-Sanz MM, Molina R et al. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer. Clin Cancer Res 2005;11:4770-4.
29. Nagata S. Early work on the function of CD95, an interview with Shige Nagata. Cell Death Differ 2004;11(suppl. 1):23-7.
30. Panwar P, Pandey B, Lakhera PC, Singh KP. Preparation, characterization, and in vitro release study of albendazoleencapsulated nanosize liposome. Int J Nanomedicine 2010;5:101-8.
31. Pasetto LM, Falci C, Basso U, Gasparini G, D'Andrea M, Bonginelli P et al. Adjuvant treatment for elderly patients with colon cancer. An observational study. Anticancer Res 2008;28:2513-8.
32. Peng G, Zhong C, Zhang Q, Xie Y, Gong F. Effect of formaldehyde on of Fas apoptosis pathway-related genes of ovary tissues in female rats. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010;35:341-5.
33. Saito R, Bringas JR, McKnight TR, Wendland MF, Mamot C, Drummond DC. Distribution of liposome into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res 2004;64:2572-9.
34. Schug ZT, Gonzalvez F, Houtkooper RH, Vaz FM, Gottlieb E. BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane. Cell Death Differ 2011;18:538-48.
35. Suh SH, Kwon HC, Jo JH, Cho YR, Seo BG, Lee DM et al. Oxaliplatin with biweekly low dose leucovorin and bolus and continuous infusion of 5-fluorouracil (modified FOLFOX4) as a salvage therapy for patients with advanced gastric cancer. Cancer Res Treat 2005;37:279-83.
36. Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoguchi N et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 2008;346:143-50.
37. Utsunomiya T, Tanaka T, Utsunomiya H, Umesaki N. A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis. Int J Oncol 2008;32:991-1000.
38. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000;256:58-66.
39. Zalipsky S, Brandeis E, Newman MS, Woodle MC. Long circulating, cationic liposome containing amino-PEGphosphatidylethanolamine. FEBS Lett 1994;53:71-4.
40. Zielińska K, Kozłowska K, Cichorek M, Wachulska M. Fas and FasL expression on cells of two transplantable melanoma lines according to their different biological properties. Folia Histochem Cytobiol 2008;46:337-43.